Table 2.
Reference | IF | Object | Intervening measures | Results |
---|---|---|---|---|
Thomas C. Beck et al. (2014) | 10.892 | B cells | Interrupt the CXCR4 signal | The export of immature B cells from BM is dependent on double downregulation of CXCR4 |
Yuval Gavriel et al. (2020) | 3.517 | AD | Combined use of AMD3100 and l‐lactic acid in the treatment of AD | The combined treatment resulted in a significant improvement in cognitive/memory functions and attenuated neuroinflammation |
Simona Capsoni et al. (2017) | 11.814 | AD | Mimic the parenchymal delivery of hNGFp used in clinical trials and intranasal injection of the same dose of hNGFp | 2hNGFp acts on glial cells and regulates inflammatory proteins by regulating CXCL12 |
Note: Research on CXCR4 and CXCL12 over the recent years.
Abbreviations: AD, Alzheimer's disease; BM, bone marrow; CXCL12, CXC motif ligand 12; CXCR4, chemokine receptor type 4; hNGFp, human painless nerve growth factor.